{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:35:24Z","timestamp":1790386524499,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.vaccine.2005.03.007","type":"journal-article","created":{"date-parts":[[2005,4,7]],"date-time":"2005-04-07T21:50:49Z","timestamp":1112910649000},"page":"3902-3907","source":"Crossref","is-referenced-by-count":28,"title":["Potency requirements of rabies vaccines administered intradermally using the Thai Red Cross regimen: investigation of the immunogenicity of serially diluted purified chick embryo cell rabies vaccine"],"prefix":"10.1016","volume":"23","author":[{"given":"Jiri","family":"Beran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Honegr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Banzhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudius","family":"Malerczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2005.03.007_bib1","unstructured":"Knobel DL, Cleaveland S, Coleman PG, F\u00e8vre EM, Meltzer MI, Miranda MEG, Shaw A, Zinsstag J, Meslin FX. Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ, in press."},{"key":"10.1016\/j.vaccine.2005.03.007_bib2","unstructured":"WHO. WHO world survey of rabies no. 33; 1997."},{"key":"10.1016\/j.vaccine.2005.03.007_bib3","unstructured":"Matouch O. Vzteklina byla v \u010cR eliminov\u00e1na (rabies was eliminated in the Czech Republic). Zpr\u00e1vy CEM (SZ\u00da, Praha) 2004;13(9):389\u2013390."},{"key":"10.1016\/j.vaccine.2005.03.007_bib4","unstructured":"WHO. WHO expert committee on rabies. WHO Technical Report Series, 824; 1992. p. 1\u201384."},{"key":"10.1016\/j.vaccine.2005.03.007_bib5","unstructured":"WHO. WHO recommendations on rabies post-exposure treatment and the correct technique of intradermal immunization against rabies; 1997. p. 1\u201326."},{"key":"10.1016\/j.vaccine.2005.03.007_bib6","unstructured":"WHO. Intradermal application of rabies vaccines: report of a WHO consultation. Bangkok; 2000."},{"issue":"5","key":"10.1016\/j.vaccine.2005.03.007_bib7","first-page":"375","article-title":"Elimination of human rabies in a canine endemic province in Thailand: five-year programme","volume":"81","author":"Kamoltham","year":"2003","journal-title":"Bull World Health Organ"},{"issue":"14","key":"10.1016\/j.vaccine.2005.03.007_bib8","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.vaccine.2004.09.027","article-title":"Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1mL PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals","volume":"23","author":"Quiambao","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.03.007_bib9","unstructured":"WHO. Recommendations of the WHO interregional consultation on strategies for the control and elimination of rabies in Asia, 17\u201320 July 2001. Geneva: WHO, 2002."},{"issue":"5","key":"10.1016\/j.vaccine.2005.03.007_bib10","first-page":"693","article-title":"Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine","volume":"78","author":"Briggs","year":"2000","journal-title":"Bull World Health Organ"},{"issue":"2","key":"10.1016\/j.vaccine.2005.03.007_bib11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0035-9203(99)90309-7","article-title":"Immunogenicity and safety of low-dose intradermal rabies vaccine given during an expanded programme on immunization session in Viet Nam: results of a comparative randomized trial","volume":"93","author":"Lang","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2005.03.007_bib12","series-title":"Laboratory Techniques in Rabies","first-page":"181","article-title":"A rapid tissue culture test for determining rabies-neutralizing antibody","author":"Smith","year":"1996"},{"key":"10.1016\/j.vaccine.2005.03.007_bib13","series-title":"Rabies","first-page":"372","article-title":"Vaccines","author":"Briggs","year":"2002"},{"issue":"25","key":"10.1016\/j.vaccine.2005.03.007_bib14","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1056\/NEJMcp042140","article-title":"Clinical practice prophylaxis against rabies","volume":"351","author":"Rupprecht","year":"2004","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2005.03.007_bib15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/infdis\/156.1.50","article-title":"Rabies post-exposure prophylaxis with human diploid cell rabies vaccine: a dose\u2013response study","volume":"156","author":"Fishbein","year":"1987","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2005.03.007_bib16","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/0264-410X(94)90308-5","article-title":"A simplified and economical intradermal regimen of purified chick embryo cell rabies vaccine for postexposure prophylaxis","volume":"12","author":"Suntharasamai","year":"1994","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05003622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05003622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T17:23:05Z","timestamp":1548609785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05003622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":16,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0264410X05003622"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.03.007","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}